<html>
    <head>
 <link rel="stylesheet" href="styles.css">
    </head>
    <body>
<div class="pabigat" style="height:auto;"><h2>Reference</h2><hr>
    <ul>
<li>1.NHS England, NHS Improvement (2020) Clinical guide for the management of anticoagulant services during the coronavirus pandemic, accessed. https://www.nice.org.uk/Media/Default/About/COVID-19/Specialty-guides/specialty-guide-anticoagulant-services-and-coronavirus.pdf. 14 Mar 2024.Google Scholar</li>
<li>2.Afzal S, Zaidi STR, Merchant HA, et al. (2021) Prescribing trends of oral anticoagulants in England over the last decade: a focus on new and old drugs and adverse events reporting. J Thromb Thrombolysis 52 (2):646–653, doi:10.1007/s11239-021-02416-4, pmid:33666824.CrossRefPubMedGoogle Scholar</li>
<li>3.Medicines and Healthcare products Regulatory Agency (2020) Direct-acting oral anticoagulants (DOACs): reminder of bleeding risk, including availability of reversal agents. Drug Safety Update 13 (11). 2.Google</li>
<li>4.Joint Formulary Committee British National Formulary [online] (London: BMJ Group and Pharmaceutical press). 2024. accessed. http://www.medicinescomplete.com. 14 Mar 2024.Google Scholar</li>
<li>5.Medicines and Healthcare products Regulatory Agency (2019) Prescribing medicines in renal impairment using the appropriate estimate of renal function to avoid the risk of adverse drug reactions. Drug Safety Update 13 . 3.Google Scholar</li>
<li>6.National Institute for Health and Care Excellence (NICE) Anticoagulation — oral. 2023. accessed. https://cks.nice.org.uk/topics/anticoagulation-oral/. 14 Mar 2024.Google Scholar</li>
<li>7.Curtis HJ, MacKenna B, Walker AJ, et al. (2021) OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic. Open Heart 8 (2), doi:10.1136/openhrt-2021-001784, pmid:34785588. e001784.Abstract/FREE Full TextGoogle Scholar</li>
<li>8.Fisher L, Speed V, Curtis HJ, et al. (2022) Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A Federated analysis of 57.9 million patients’ primary care records in situ using OpenSAFELY. Thromb Res 211 150–153, doi:10.1016/j.thromres.2022.01.023, pmid:35168181. S0049-3848(22)00030-5.CrossRefPubMedGoogle Scholar</li>
<li>9.NICE Scenario: Edoxaban. 2023. accessed. https://cks.nice.org.uk/topics/anticoagulation-oral/management/edoxaban/. 14 Mar 2024.Google Scholar</li>
<li>10.NHS Business Services Authority (2023) Pseudo anonymised patient level prescribed and dispensed data set January 2018 to February 2023, accessed April 2023.Google Scholar</li>
<li>11.Khachatryan A, Doobaree IU, Spentzouris G, et al. (2023) Direct oral anticoagulant (DOAC) dosing in patients with non-valvular atrial fibrillation (NVAF) in the United kingdom: A retrospective cohort study using CPRD Gold database. Adv Ther 40 (2):504–520, doi:10.1007/s12325-022-02368-y, pmid:36399317.CrossRefPubMedGoogle Scholar</li>
<li>12.NHS England (2021) Annex B – Investment and Impact Fund (IIF): 2021/22 and 2022/23, accessed. https://www.england.nhs.uk/wp-content/uploads/2021/08/B0828-iii-annex-b-investment-and-impact-fund-21-22-22-23.pdf. 14 Mar 2024.Google Scholar</li>
<li>13.Santos J, António N, Rocha M, Fortuna A (2020) Impact of direct oral anticoagulant off-label doses on clinical outcomes of atrial fibrillation patients: a systematic review. Br J Clin Pharmacol 86 (3):533–547, doi:10.1111/bcp.14127, pmid:31631392.CrossRefPubMedGoogle Scholar</li>
<li>14.Erskine D (2019) DOAC dosing in renal impairment. Drug Ther Bull 57 (4), doi:10.1136/dtb.2019.000013, pmid:30918002. 50.FREE Full TextGoogle Scholar</li>
<li>15.Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16 (1):31–41, doi:10.1159/000180580, pmid:1244564.CrossRefPubMedGoogle Scholar</li>
<li>16.NHS England (2023) The NHS England OpenSAFELY COVID-19 service — privacy notice. accessed. https://digital.nhs.uk/coronavirus/coronavirus-covid-19-response-information-governance-hub/the-nhs-england-opensafely-covid-19-service-privacy-notice. 14 Mar 2024.Google Scholar</li>
<li>17.NHS England (2023) Data security and protection toolkit. accessed. https://digital.nhs.uk/data-and-information/looking-after-information/data-security-and-information-governance/data-security-and-protection-toolkit. 14 Mar 2024.Google Scholar</li>
<li>18.NHS England (2022) ISB1523: Anonymisation standard for publishing health and social care data. accessed. https://digital.nhs.uk/data-and-information/information-standards/information-standards-and-data-collections-including-extractions/publications-and-notifications/standards-and-collections/isb1523-anonymisation-standard-for-publishing-health-and-social-care-data. 14 Mar 2024.Google Scholar</li>
<li>19.Department of Health and Social Care (2022) [Withdrawn] Coronavirus (COVID-19): notice under regulation 3(4) of the Health Service (Control of Patient Information) Regulations 2002 — general. accessed. https://www.gov.uk/government/publications/coronavirus-covid-19-notification-of-data-controllers-to-share-information/coronavirus-covid-19-notice-under-regulation-34-of-the-health-service-control-of-patient-information-regulations-2002-general--2. 14 Mar 2024.Google Scholar</li>
<li>20.NHS England (2020) COVID-19 public health directions 2020. accessed. https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/secretary-of-state-directions/covid-19-public-health-directions-2020. 14 Mar 2024.Google Scholar</li>
<li>21.NHS Health Research Authority (2023) Confidentiality Advisory Group, accessed. https://www.hra.nhs.uk/about-us/committees-and-services/confidentiality-advisory-group/. 14 Mar 2024.Google Scholar</li>
    </ul>
</div>